Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation

Kazushi Morimoto, Naritoshi Shirata, Yoshitaka Taketomi, Soken Tsuchiya, Eri Segi-Nishida, Tomoaki Inazumi, Kenji Kabashima, Satoshi Tanaka, Makoto Murakami, Shuh Narumiya, Yukihiko Sugimoto

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

PGE2 has long been known as a potentiator of acute inflammation, but its mechanisms of action still remain to be defined. In this study, we employed inflammatory swelling induced in mice by arachidonate and PGE2 as models and dissected the role and mechanisms of action of each EP receptor at the molecular level. Arachidonate- or PGE2-induced vascular permeability was significantly reduced in EP3-deficient mice. Intriguingly, the PGE2-induced response was suppressed by histamine H1 antagonist treatment, histidine decarboxylase deficiency, and mast cell deficiency. The impaired PGE2-induced response in mast cell-deficient mice was rescued upon reconstitution with wild-type mast cells but not with EP3-deficient mast cells. Although the number of mast cells, protease activity, and histamine contents in ear tissues in EP3-deficient mice were comparable to those in wild-type mice, the histamine contents in ear tissues were attenuated upon PGE2 treatment in wild-type but not in EP3-deficient mice. Consistently, PGE2-EP3 signaling elicited histamine release in mouse peritoneal and bone marrow-derived mast cells, and it exerted degranulation and IL-6 production in a manner sensitive to pertussis toxin and a PI3K inhibitor and dependent on extracellular Ca2+ ions. These results demonstrate that PGE2 triggers mast cell activation via an EP3-Gi/o-Ca2+ influx/PI3K pathway, and this mechanism underlies PGE2-induced vascular permeability and consequent edema formation.

Original languageEnglish
Pages (from-to)1130-1137
Number of pages8
JournalJournal of Immunology
Volume192
Issue number3
DOIs
Publication statusPublished - Feb 1 2014

Fingerprint

Dinoprostone
Mast Cells
Capillary Permeability
Phosphatidylinositol 3-Kinases
Histamine
Ear
Histamine H1 Antagonists
Histidine Decarboxylase
Histamine Release
Pertussis Toxin
Interleukin-6
Edema
Peptide Hydrolases
Bone Marrow
Ions
Inflammation

ASJC Scopus subject areas

  • Immunology

Cite this

Morimoto, K., Shirata, N., Taketomi, Y., Tsuchiya, S., Segi-Nishida, E., Inazumi, T., ... Sugimoto, Y. (2014). Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. Journal of Immunology, 192(3), 1130-1137. https://doi.org/10.4049/jimmunol.1300290

Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. / Morimoto, Kazushi; Shirata, Naritoshi; Taketomi, Yoshitaka; Tsuchiya, Soken; Segi-Nishida, Eri; Inazumi, Tomoaki; Kabashima, Kenji; Tanaka, Satoshi; Murakami, Makoto; Narumiya, Shuh; Sugimoto, Yukihiko.

In: Journal of Immunology, Vol. 192, No. 3, 01.02.2014, p. 1130-1137.

Research output: Contribution to journalArticle

Morimoto, K, Shirata, N, Taketomi, Y, Tsuchiya, S, Segi-Nishida, E, Inazumi, T, Kabashima, K, Tanaka, S, Murakami, M, Narumiya, S & Sugimoto, Y 2014, 'Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation', Journal of Immunology, vol. 192, no. 3, pp. 1130-1137. https://doi.org/10.4049/jimmunol.1300290
Morimoto K, Shirata N, Taketomi Y, Tsuchiya S, Segi-Nishida E, Inazumi T et al. Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. Journal of Immunology. 2014 Feb 1;192(3):1130-1137. https://doi.org/10.4049/jimmunol.1300290
Morimoto, Kazushi ; Shirata, Naritoshi ; Taketomi, Yoshitaka ; Tsuchiya, Soken ; Segi-Nishida, Eri ; Inazumi, Tomoaki ; Kabashima, Kenji ; Tanaka, Satoshi ; Murakami, Makoto ; Narumiya, Shuh ; Sugimoto, Yukihiko. / Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation. In: Journal of Immunology. 2014 ; Vol. 192, No. 3. pp. 1130-1137.
@article{f13d276efbf4472296311cfc9cf25e35,
title = "Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation",
abstract = "PGE2 has long been known as a potentiator of acute inflammation, but its mechanisms of action still remain to be defined. In this study, we employed inflammatory swelling induced in mice by arachidonate and PGE2 as models and dissected the role and mechanisms of action of each EP receptor at the molecular level. Arachidonate- or PGE2-induced vascular permeability was significantly reduced in EP3-deficient mice. Intriguingly, the PGE2-induced response was suppressed by histamine H1 antagonist treatment, histidine decarboxylase deficiency, and mast cell deficiency. The impaired PGE2-induced response in mast cell-deficient mice was rescued upon reconstitution with wild-type mast cells but not with EP3-deficient mast cells. Although the number of mast cells, protease activity, and histamine contents in ear tissues in EP3-deficient mice were comparable to those in wild-type mice, the histamine contents in ear tissues were attenuated upon PGE2 treatment in wild-type but not in EP3-deficient mice. Consistently, PGE2-EP3 signaling elicited histamine release in mouse peritoneal and bone marrow-derived mast cells, and it exerted degranulation and IL-6 production in a manner sensitive to pertussis toxin and a PI3K inhibitor and dependent on extracellular Ca2+ ions. These results demonstrate that PGE2 triggers mast cell activation via an EP3-Gi/o-Ca2+ influx/PI3K pathway, and this mechanism underlies PGE2-induced vascular permeability and consequent edema formation.",
author = "Kazushi Morimoto and Naritoshi Shirata and Yoshitaka Taketomi and Soken Tsuchiya and Eri Segi-Nishida and Tomoaki Inazumi and Kenji Kabashima and Satoshi Tanaka and Makoto Murakami and Shuh Narumiya and Yukihiko Sugimoto",
year = "2014",
month = "2",
day = "1",
doi = "10.4049/jimmunol.1300290",
language = "English",
volume = "192",
pages = "1130--1137",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "3",

}

TY - JOUR

T1 - Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation

AU - Morimoto, Kazushi

AU - Shirata, Naritoshi

AU - Taketomi, Yoshitaka

AU - Tsuchiya, Soken

AU - Segi-Nishida, Eri

AU - Inazumi, Tomoaki

AU - Kabashima, Kenji

AU - Tanaka, Satoshi

AU - Murakami, Makoto

AU - Narumiya, Shuh

AU - Sugimoto, Yukihiko

PY - 2014/2/1

Y1 - 2014/2/1

N2 - PGE2 has long been known as a potentiator of acute inflammation, but its mechanisms of action still remain to be defined. In this study, we employed inflammatory swelling induced in mice by arachidonate and PGE2 as models and dissected the role and mechanisms of action of each EP receptor at the molecular level. Arachidonate- or PGE2-induced vascular permeability was significantly reduced in EP3-deficient mice. Intriguingly, the PGE2-induced response was suppressed by histamine H1 antagonist treatment, histidine decarboxylase deficiency, and mast cell deficiency. The impaired PGE2-induced response in mast cell-deficient mice was rescued upon reconstitution with wild-type mast cells but not with EP3-deficient mast cells. Although the number of mast cells, protease activity, and histamine contents in ear tissues in EP3-deficient mice were comparable to those in wild-type mice, the histamine contents in ear tissues were attenuated upon PGE2 treatment in wild-type but not in EP3-deficient mice. Consistently, PGE2-EP3 signaling elicited histamine release in mouse peritoneal and bone marrow-derived mast cells, and it exerted degranulation and IL-6 production in a manner sensitive to pertussis toxin and a PI3K inhibitor and dependent on extracellular Ca2+ ions. These results demonstrate that PGE2 triggers mast cell activation via an EP3-Gi/o-Ca2+ influx/PI3K pathway, and this mechanism underlies PGE2-induced vascular permeability and consequent edema formation.

AB - PGE2 has long been known as a potentiator of acute inflammation, but its mechanisms of action still remain to be defined. In this study, we employed inflammatory swelling induced in mice by arachidonate and PGE2 as models and dissected the role and mechanisms of action of each EP receptor at the molecular level. Arachidonate- or PGE2-induced vascular permeability was significantly reduced in EP3-deficient mice. Intriguingly, the PGE2-induced response was suppressed by histamine H1 antagonist treatment, histidine decarboxylase deficiency, and mast cell deficiency. The impaired PGE2-induced response in mast cell-deficient mice was rescued upon reconstitution with wild-type mast cells but not with EP3-deficient mast cells. Although the number of mast cells, protease activity, and histamine contents in ear tissues in EP3-deficient mice were comparable to those in wild-type mice, the histamine contents in ear tissues were attenuated upon PGE2 treatment in wild-type but not in EP3-deficient mice. Consistently, PGE2-EP3 signaling elicited histamine release in mouse peritoneal and bone marrow-derived mast cells, and it exerted degranulation and IL-6 production in a manner sensitive to pertussis toxin and a PI3K inhibitor and dependent on extracellular Ca2+ ions. These results demonstrate that PGE2 triggers mast cell activation via an EP3-Gi/o-Ca2+ influx/PI3K pathway, and this mechanism underlies PGE2-induced vascular permeability and consequent edema formation.

UR - http://www.scopus.com/inward/record.url?scp=84893355942&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893355942&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.1300290

DO - 10.4049/jimmunol.1300290

M3 - Article

C2 - 24342806

AN - SCOPUS:84893355942

VL - 192

SP - 1130

EP - 1137

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 3

ER -